# Symptom Control Satisfaction With Proton Pump Inhibitor Regimen

> **NCT02623816** · PHASE4 · COMPLETED · sponsor: **MetroHealth Medical Center** · enrollment: 64 (actual)

## Conditions studied

- Heartburn

## Interventions

- **DRUG:** Optimal Dosing of Omeprazole

## Key facts

- **NCT ID:** NCT02623816
- **Lead sponsor:** MetroHealth Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2022-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02623816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02623816, "Symptom Control Satisfaction With Proton Pump Inhibitor Regimen". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02623816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*